Sutent and Grand mal convulsion - a phase IV clinical study of FDA data

Summary:

Grand mal convulsion is reported as a side effect among people who take Sutent (sunitinib malate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lisinopril, and have Metastatic renal cell carcinoma.

The phase IV clinical study analyzes which people have Grand mal convulsion when taking Sutent. It is created by eHealthMe based on reports of 44,359 people who have side effects when taking Sutent from the FDA, and is updated regularly.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

What is Grand mal convulsion?

Grand mal convulsion (a type of generalized seizure that affects the entire brain) is found to be associated with 921 drugs and 1,337 conditions by eHealthMe. Check the latest studies of Grand mal convulsion.

On Jul, 28, 2026

44,359 people reported to have side effects when taking Sutent.
Among them, 44 people (0.1%) have Grand mal convulsion.

Could Sutent cause Grand mal convulsion?

Among these 44 people:

How long have people been on Sutent when they have Grand mal convulsion? *

What is the gender of people who have Grand mal convulsion when taking Sutent? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Grand mal convulsion when taking Sutent? *

What are other drugs people take besides Sutent? *

What are other side effects people have besides Grand mal convulsion? *

High Blood Pressure: 14 people, 31.82%
Fatigue (feeling of tiredness): 11 people, 25.00%
Hypotension (abnormally low blood pressure): 10 people, 22.73%
Confusional State: 9 people, 20.45%
Nausea (feeling of having an urge to vomit): 8 people, 18.18%
Common Peroneal Nerve Dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes): 7 people, 15.91%
Encephalopathy (functioning of the brain is affected by some agent or condition): 7 people, 15.91%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 7 people, 15.91%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 7 people, 15.91%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 7 people, 15.91%

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 15 people, 34.09%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 12 people, 27.27%
Prostate Cancer: 4 people, 9.09%
Pain: 4 people, 9.09%
High Blood Pressure: 4 people, 9.09%
Gastrointestinal Stromal Tumor: 4 people, 9.09%
Bone Neoplasm Malignant (cancer of bone): 4 people, 9.09%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Sutent and have Grand mal convulsion?

- Check whether Grand mal convulsion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sutent:

Sutent (44,554 reports)

Browse all side effects of Sutent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Grand mal convulsion:

Grand mal convulsion (921 drugs)

Browse all the conditions that are associated with Grand mal convulsion:

Grand mal convulsion (1,337 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sunitinib malate (the active ingredients of Sutent) and Sutent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.